Solazyme (SZYM) Posts Q1 Loss of 21c/Share, Beats Views

Solazyme (NASDAQ: SZYM) reported Q1 EPS of ($0.21), $0.09 better than the analyst estimate of ($0.30). Revenue for the quarter came in at $13.6 million versus the consensus estimate of $10.48 million.

For earnings history and earnings-related data on Solazyme (SZYM) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Nomura/Instinet Upgrades Genting Singapore (GENS:SP) (GIGNY) to Neutral
• LogicBio Therapeutics (LOGC) Misses Q2 EPS by 10c
• Birchtech Corp. (BCHT) Misses Q2 EPS by 7c